Rhabdomyosarcoma Market Statistics : Product, Overview and Share Forecast

Market Highlights

Rhabdomyosarcoma is anticipated to grow at a CAGR of ~4.8%. Rhabdomyosarcoma or RMS is a type of soft tissue cancer. It is rare cancer and affects the skeletal muscle tissue. Sometimes, it also affects the hollow organs like uterus or bladder. RMS can affect people of any age, but it mostly affects children. The increasing prevalence of rhabdomyosarcoma, rising research & development expenditure and useful molecules in the pipeline are expected to drive the growth of the market during the forecast period. Additionally, the increasing awareness among people is likely to boost the market growth. On the other hand, high treatment costs, side effects of the treatment, improper results of the drugs in the pipeline and strict government regulations may hinder the growth of the market during the forecast period.

 Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/6569

 The global rhabdomyosarcoma market is currently dominated by many market players. The key players in the market are engaging themselves in new product launches and strategic collaborations to strengthen its market position. For instance, in December 2016, Pfizer USD 6 million in Bioinvent for Myeloid Cell Antibody partnership. Bioinvent has a few cancer drugs in the pipeline, like the TB-403, a monoclonal antibody which targets placental growth factor, as a possible treatment for alveolar rhabdomyosarcoma, medulloblastoma, etc. This drug is in its Phase 2 trials.

 Regional Analysis

The market in the Americas is expected to dominate the global rhabdomyosarcoma market during the forecast period owing to the high prevalence of rhabdomyosarcoma and well-established healthcare infrastructure. According to an article published by the American Society of Clinical Oncology in January 2018, about 350 children are diagnosed with rhabdomyosarcoma every year. The European market is expected to be the second-largest due to the well-developed healthcare infrastructure in the region. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to favorable government initiatives for enhancing healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global rhabdomyosarcoma market. The market growth in this region can be attributed to the increases cases of rhabdomyosarcoma.

 Segmentation

The global Rhabdomyosarcoma Market Statistics  has been segmented into type, treatment, and diagnosis.

The market, based on type, has been segmented into Embryonal Rhabdomyosarcoma, and Alveolar Rhabdomyosarcoma. Alveolar rhabdomyosarcoma is expected to account for the largest market share in this segment owing to its rising prevalence. It is also anticipated to be the fastest growing market.

The market, by diagnosis, has been segmented into Imaging Tests and Biopsy.

According to diagnosis, imaging tests have been segmented into X-Ray, CT scan, MRI scan, PET scan, and Bone scan.

According to diagnosis, biopsy has been segmented into Needle Biopsy and Surgical Biopsy.

The market, by treatment, has been segmented into Surgery, Radiation Therapy, Chemotherapy and Stem Cell Therapy.

 Key Players

Some of the key players in the global rhabdomyosarcoma market are Eli Lilly & Company, Boehringer Ingelheim International GmbH, Pfizer Inc, Novartis AG, Bristol Myers Squibb Company, Oasmia, Bellicum Pharmaceuticals, Inc., CELGENE CORPORATION, Eisai Co., Ltd., MacroGenics, Inc., NantKwest., TAIHO ONCOLOGY, INC., Tarveda Therapeutics., Exelixis, Inc., and Ipsen Pharma.

 Access Report @ 

https://www.marketresearchfuture.com/reports/rhabdomyosarcoma-market-6569

 NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Cosmetic Dentistry Market Size By Application, Growth Potential, Price Trend & Forecast

  Market Highlights Cosmetic dentistry is the dental work that helps improve the look of a person's teeth. The treatment includes teeth whitening, straightening, reshaping, and realignment. There are several other cosmetic dental services, which include cosmetic gum surgery, tooth contouring and reshaping, tooth colored fillings, composite bonding, dental implants, and inlays and onlays. Technological advancements have also allowed the application of novel techniques. The high cost of dental imaging procedures and lack of reimbursement options hinder the growth of this market. The global cosmetic dentistry market is dominated by many key market players. These players are engaged in new product launches and tactical partnerships to brace their market position. For instance, in April 2017, Zimmer Biomet Holdings, Inc. announced the distribution of NovaBone Dental Putty in over 40 countries within the Middle East, Africa, Latin America, Asia-Pacific, and the selected markets in Europe...
Read more

Animal Health Market Trends By Excellent Opportunities, Industry Growth, Size, And Statistics Forecasts 

  The demand within the Global “Animal Health Market Research Report – Forecast to 2023” has been rising due to the several approaches like technology advancements and heavy competition.   The global animal health market is predicted to touch USD 38,500 million at a 5.7% CAGR over the forecast period (2018-2023), states the latest Market Research Future (MRFR) report. Animal health, simply put, is a branch of veterinary science that deals with monitoring and treatment of animal disease. It plays a crucial part in the safety and economy of the food supply of the country.   Various factors are propelling the animal health market growth. Some of these factors, according to the Market Research Future report, include rising pet insurance, increasing incidences of zoonotic diseases, growing pet population, and rising expenditure on animal health. Additional factors pushing market growth include rising pet ownership, increasing emphasis on food safety, improvement in product...
Read more

Carrier Screening Market with (Covid-19) Impact Analysis: Worldwide Key Industry Segments & Forecast

  Market Analysis  The global carrier screening market is anticipated to touch USD 4,200 million at a 16.8% CAGR between 2019- 2025, according to the new report by Market Research Future (MRFR). Carrier screening, simply put, is a genetic test that is used for determining whether a healthy individual is a carrier of any recessive genetic disease. It has wide applications in clinics, physician offices, reference laboratories, hospitals, and others.  Request Sample Copy: https://www.marketresearchfuture.com/sample_request/8755 Market Segmentation  The MRFR report gives an inclusive segmental analysis of the global carrier screening market report based on end users, technology, medical condition, type, and product & service.  By product and service, the global carrier screening market is segmented into products & services. Of these, the product segment will lead the market over the forecast period, followed by the services segment that is likely to gro...
Read more